These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19559402)

  • 1. Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume.
    Stone JM; Day F; Tsagaraki H; Valli I; McLean MA; Lythgoe DJ; O'Gorman RL; Barker GJ; McGuire PK;
    Biol Psychiatry; 2009 Sep; 66(6):533-9. PubMed ID: 19559402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis.
    Fusar-Poli P; Stone JM; Broome MR; Valli I; Mechelli A; McLean MA; Lythgoe DJ; O'Gorman RL; Barker GJ; McGuire PK
    Arch Gen Psychiatry; 2011 Sep; 68(9):881-90. PubMed ID: 21536967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered medial temporal activation related to local glutamate levels in subjects with prodromal signs of psychosis.
    Valli I; Stone J; Mechelli A; Bhattacharyya S; Raffin M; Allen P; Fusar-Poli P; Lythgoe D; O'Gorman R; Seal M; McGuire P
    Biol Psychiatry; 2011 Jan; 69(1):97-9. PubMed ID: 21035785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
    Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
    Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletion.
    Rogdaki M; Hathway P; Gudbrandsen M; McCutcheon RA; Jauhar S; Daly E; Howes O
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1333-1342. PubMed ID: 31648854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia.
    Théberge J; Williamson KE; Aoyama N; Drost DJ; Manchanda R; Malla AK; Northcott S; Menon RS; Neufeld RW; Rajakumar N; Pavlosky W; Densmore M; Schaefer B; Williamson PC
    Br J Psychiatry; 2007 Oct; 191():325-34. PubMed ID: 17906243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla.
    Bustillo JR; Chen H; Gasparovic C; Mullins P; Caprihan A; Qualls C; Apfeldorf W; Lauriello J; Posse S
    Biol Psychiatry; 2011 Jan; 69(1):19-27. PubMed ID: 20970118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T.
    Bustillo JR; Chen H; Jones T; Lemke N; Abbott C; Qualls C; Canive J; Gasparovic C
    JAMA Psychiatry; 2014 Mar; 71(3):265-72. PubMed ID: 24402128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grey matter and social functioning correlates of glutamatergic metabolite loss in schizophrenia.
    Aoyama N; Théberge J; Drost DJ; Manchanda R; Northcott S; Neufeld RW; Menon RS; Rajakumar N; Pavlosky WF; Densmore M; Schaefer B; Williamson PC
    Br J Psychiatry; 2011 Jun; 198(6):448-56. PubMed ID: 21628707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study.
    Modinos G; McLaughlin A; Egerton A; McMullen K; Kumari V; Barker GJ; Keysers C; Williams SC
    Transl Psychiatry; 2017 Apr; 7(4):e1083. PubMed ID: 28375210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers.
    Théberge J; Bartha R; Drost DJ; Menon RS; Malla A; Takhar J; Neufeld RW; Rogers J; Pavlosky W; Schaefer B; Densmore M; Al-Semaan Y; Williamson PC
    Am J Psychiatry; 2002 Nov; 159(11):1944-6. PubMed ID: 12411236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study.
    Jauhar S; McCutcheon R; Borgan F; Veronese M; Nour M; Pepper F; Rogdaki M; Stone J; Egerton A; Turkheimer F; McGuire P; Howes OD
    Lancet Psychiatry; 2018 Oct; 5(10):816-823. PubMed ID: 30236864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
    Merritt K; Egerton A; Kempton MJ; Taylor MJ; McGuire PK
    JAMA Psychiatry; 2016 Jul; 73(7):665-74. PubMed ID: 27304221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.
    Yoo SY; Yeon S; Choi CH; Kang DH; Lee JM; Shin NY; Jung WH; Choi JS; Jang DP; Kwon JS
    Schizophr Res; 2009 Jun; 111(1-3):86-93. PubMed ID: 19406622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
    Natsubori T; Inoue H; Abe O; Takano Y; Iwashiro N; Aoki Y; Koike S; Yahata N; Katsura M; Gonoi W; Sasaki H; Takao H; Kasai K; Yamasue H
    Schizophr Bull; 2014 Sep; 40(5):1128-39. PubMed ID: 24023251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalamic neurochemical abnormalities in individuals with prodromal symptoms of schizophrenia - relationship to auditory event-related potentials.
    Stone JM; Bramon E; Pauls A; Sumich A; McGuire PK
    Psychiatry Res; 2010 Aug; 183(2):174-6. PubMed ID: 20620033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroanatomical changes in people with high schizotypy: relationship to glutamate levels.
    Modinos G; Egerton A; McLaughlin A; McMullen K; Kumari V; Lythgoe DJ; Barker GJ; Aleman A; Williams SCR
    Psychol Med; 2018 Aug; 48(11):1880-1889. PubMed ID: 29198207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance use and regional gray matter volume in individuals at high risk of psychosis.
    Stone JM; Bhattacharyya S; Barker GJ; McGuire PK
    Eur Neuropsychopharmacol; 2012 Feb; 22(2):114-22. PubMed ID: 21741803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1H-MRS at 4 tesla in minimally treated early schizophrenia.
    Bustillo JR; Rowland LM; Mullins P; Jung R; Chen H; Qualls C; Hammond R; Brooks WM; Lauriello J
    Mol Psychiatry; 2010 Jun; 15(6):629-36. PubMed ID: 19918243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.
    Abbott C; Bustillo J
    Curr Opin Psychiatry; 2006 Mar; 19(2):135-9. PubMed ID: 16612192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.